Natural approaches in metabolic syndrome management

Angelo Maria Patti, Khalid Al-Rasadi, Rosaria Vincenza Giglio, Dragana Nikolic, Carlo Mannina, Giuseppa Castellino, Roberta Chianetta, MacIej Banach, Arrigo F.G. Cicero, Giuseppe Lippi, Giuseppe Montalto, Manfredi Rizzo, Peter P. Toth

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Metabolic syndrome (MetS) is characterized as a group of cardiometabolic risk factors that raise the risk for heart disease and other health problems, such as diabetes mellitus and stroke. Treatment strategies include pharmacologic interventions and supplementary (or "alternative") treatments. Nutraceuticals are derived from food sources (isolated nutrients, dietary supplements and herbal products) that are purported to provide health benefits, in addition to providing basic nutritional value. Nutraceuticals are claimed to prevent chronic diseases, improve health, delay the aging process, increase life expectancy, and support the structure and function of the body. The study of the beneficial effects of nutraceuticals in patients with MetS, including product standardization, duration of supplementation and definition of optimal dosing, could help better define appropriate treatment. This review focuses on widely marketed nutraceuticals (namely polyphenols, omega-3 fatty acids, macroelements and vitamins) with clinically demonstrated effects on more than one component of MetS.

Original languageEnglish
Pages (from-to)422-441
Number of pages20
JournalArchives of Medical Science
Volume14
Issue number2
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Dietary Supplements
Food
Nutritive Value
Health
Omega-3 Fatty Acids
Polyphenols
Insurance Benefits
Life Expectancy
Vitamins
Heart Diseases
Diabetes Mellitus
Chronic Disease
Therapeutics
Stroke

Keywords

  • Cardiovascular risk
  • Macroelements
  • Metabolic syndrome
  • Nutraceuticals
  • Omega-3 fatty acids
  • Polyphenols
  • Vitamins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Patti, A. M., Al-Rasadi, K., Giglio, R. V., Nikolic, D., Mannina, C., Castellino, G., ... Toth, P. P. (2018). Natural approaches in metabolic syndrome management. Archives of Medical Science, 14(2), 422-441. https://doi.org/10.5114/aoms.2017.68717

Natural approaches in metabolic syndrome management. / Patti, Angelo Maria; Al-Rasadi, Khalid; Giglio, Rosaria Vincenza; Nikolic, Dragana; Mannina, Carlo; Castellino, Giuseppa; Chianetta, Roberta; Banach, MacIej; Cicero, Arrigo F.G.; Lippi, Giuseppe; Montalto, Giuseppe; Rizzo, Manfredi; Toth, Peter P.

In: Archives of Medical Science, Vol. 14, No. 2, 01.03.2018, p. 422-441.

Research output: Contribution to journalReview article

Patti, AM, Al-Rasadi, K, Giglio, RV, Nikolic, D, Mannina, C, Castellino, G, Chianetta, R, Banach, M, Cicero, AFG, Lippi, G, Montalto, G, Rizzo, M & Toth, PP 2018, 'Natural approaches in metabolic syndrome management', Archives of Medical Science, vol. 14, no. 2, pp. 422-441. https://doi.org/10.5114/aoms.2017.68717
Patti AM, Al-Rasadi K, Giglio RV, Nikolic D, Mannina C, Castellino G et al. Natural approaches in metabolic syndrome management. Archives of Medical Science. 2018 Mar 1;14(2):422-441. https://doi.org/10.5114/aoms.2017.68717
Patti, Angelo Maria ; Al-Rasadi, Khalid ; Giglio, Rosaria Vincenza ; Nikolic, Dragana ; Mannina, Carlo ; Castellino, Giuseppa ; Chianetta, Roberta ; Banach, MacIej ; Cicero, Arrigo F.G. ; Lippi, Giuseppe ; Montalto, Giuseppe ; Rizzo, Manfredi ; Toth, Peter P. / Natural approaches in metabolic syndrome management. In: Archives of Medical Science. 2018 ; Vol. 14, No. 2. pp. 422-441.
@article{204fef60a24e496a8c6f19ddd264f9c2,
title = "Natural approaches in metabolic syndrome management",
abstract = "Metabolic syndrome (MetS) is characterized as a group of cardiometabolic risk factors that raise the risk for heart disease and other health problems, such as diabetes mellitus and stroke. Treatment strategies include pharmacologic interventions and supplementary (or {"}alternative{"}) treatments. Nutraceuticals are derived from food sources (isolated nutrients, dietary supplements and herbal products) that are purported to provide health benefits, in addition to providing basic nutritional value. Nutraceuticals are claimed to prevent chronic diseases, improve health, delay the aging process, increase life expectancy, and support the structure and function of the body. The study of the beneficial effects of nutraceuticals in patients with MetS, including product standardization, duration of supplementation and definition of optimal dosing, could help better define appropriate treatment. This review focuses on widely marketed nutraceuticals (namely polyphenols, omega-3 fatty acids, macroelements and vitamins) with clinically demonstrated effects on more than one component of MetS.",
keywords = "Cardiovascular risk, Macroelements, Metabolic syndrome, Nutraceuticals, Omega-3 fatty acids, Polyphenols, Vitamins",
author = "Patti, {Angelo Maria} and Khalid Al-Rasadi and Giglio, {Rosaria Vincenza} and Dragana Nikolic and Carlo Mannina and Giuseppa Castellino and Roberta Chianetta and MacIej Banach and Cicero, {Arrigo F.G.} and Giuseppe Lippi and Giuseppe Montalto and Manfredi Rizzo and Toth, {Peter P.}",
year = "2018",
month = "3",
day = "1",
doi = "10.5114/aoms.2017.68717",
language = "English",
volume = "14",
pages = "422--441",
journal = "Archives of Medical Science",
issn = "1734-1922",
publisher = "Termedia Publishing House Ltd.",
number = "2",

}

TY - JOUR

T1 - Natural approaches in metabolic syndrome management

AU - Patti, Angelo Maria

AU - Al-Rasadi, Khalid

AU - Giglio, Rosaria Vincenza

AU - Nikolic, Dragana

AU - Mannina, Carlo

AU - Castellino, Giuseppa

AU - Chianetta, Roberta

AU - Banach, MacIej

AU - Cicero, Arrigo F.G.

AU - Lippi, Giuseppe

AU - Montalto, Giuseppe

AU - Rizzo, Manfredi

AU - Toth, Peter P.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Metabolic syndrome (MetS) is characterized as a group of cardiometabolic risk factors that raise the risk for heart disease and other health problems, such as diabetes mellitus and stroke. Treatment strategies include pharmacologic interventions and supplementary (or "alternative") treatments. Nutraceuticals are derived from food sources (isolated nutrients, dietary supplements and herbal products) that are purported to provide health benefits, in addition to providing basic nutritional value. Nutraceuticals are claimed to prevent chronic diseases, improve health, delay the aging process, increase life expectancy, and support the structure and function of the body. The study of the beneficial effects of nutraceuticals in patients with MetS, including product standardization, duration of supplementation and definition of optimal dosing, could help better define appropriate treatment. This review focuses on widely marketed nutraceuticals (namely polyphenols, omega-3 fatty acids, macroelements and vitamins) with clinically demonstrated effects on more than one component of MetS.

AB - Metabolic syndrome (MetS) is characterized as a group of cardiometabolic risk factors that raise the risk for heart disease and other health problems, such as diabetes mellitus and stroke. Treatment strategies include pharmacologic interventions and supplementary (or "alternative") treatments. Nutraceuticals are derived from food sources (isolated nutrients, dietary supplements and herbal products) that are purported to provide health benefits, in addition to providing basic nutritional value. Nutraceuticals are claimed to prevent chronic diseases, improve health, delay the aging process, increase life expectancy, and support the structure and function of the body. The study of the beneficial effects of nutraceuticals in patients with MetS, including product standardization, duration of supplementation and definition of optimal dosing, could help better define appropriate treatment. This review focuses on widely marketed nutraceuticals (namely polyphenols, omega-3 fatty acids, macroelements and vitamins) with clinically demonstrated effects on more than one component of MetS.

KW - Cardiovascular risk

KW - Macroelements

KW - Metabolic syndrome

KW - Nutraceuticals

KW - Omega-3 fatty acids

KW - Polyphenols

KW - Vitamins

UR - http://www.scopus.com/inward/record.url?scp=85043486843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043486843&partnerID=8YFLogxK

U2 - 10.5114/aoms.2017.68717

DO - 10.5114/aoms.2017.68717

M3 - Review article

VL - 14

SP - 422

EP - 441

JO - Archives of Medical Science

JF - Archives of Medical Science

SN - 1734-1922

IS - 2

ER -